Guest Editor

Aldosterone and the Mineralocorticoid Receptor:

Emerging Therapeutic Paradigms for
Cardiorenal Protection
Guest Editor
Tilman B. Drueke

Publication of this supplement is

sponsored by Bayer AG

This supplement was developed and organized by Dr. Murray Epstein.

The authors developed the content of the articles, made all final decisions, and take full responsibility for their
accuracy. Development of this supplement was funded by an unrestricted educational grant from Bayer AG,
which included editorial support provided by Chameleon Communications International, and illustration
support provided by CAST PHARMA.

The opinions or views expressed in this supplement are those of the authors and do not necessarily reflect the
opinions or recommendations of the International Society of Nephrology or Elsevier.

Practitioners and researchers must always rely on their own experience and knowledge in evaluating and
using any information, methods, compounds or experiments described herein. Because of rapid advances in
the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made.
To the fullest extent of the law, no responsibility is assumed by the International Society of Nephrology or
Elsevier for any injury and/or damage to persons or property as a matter of products liability, negligence or
otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the
material herein.

Official Journal of the

International Society of Nephrology

Elsevier